Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer
N/A
40 Years
N/A
40 Years
N/A
Open (Enrolling)
Both
Lung Neoplasms
Both
Lung Neoplasms
Trial Information
Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer
Inclusion Criteria:
- Current or ex-smokers who have smoked at least 20-pack-years (e.g. 1 pack per day for
20 years or more)
- Informed consent
Exclusion Criteria:
- Known malignant disease
- Unstable major medical disease
- Bleeding disorder
- Unwilling to have a bronchoscopy
- Women currently pregnant or nursing
- Known reaction to xylocaine, a local anaesthesia agent used for bronchoscopy
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Primary Purpose: Diagnostic
Outcome Measure:
Number of early stage lung cancer/precancerous lesion detected
Outcome Time Frame:
Two years
Principal Investigator
Bing Lam, Dr
Investigator Role:
Principal Investigator
Investigator Affiliation:
Department of Medicine, Queen Mary Hospital/ The University of Hong Kong
Authority:
Hong Kong: Ethics Committee
Study ID:
EC 1621-01
NCT ID:
NCT00563420
Start Date:
November 2002
Completion Date:
June 2007
Related Keywords:
- Lung Neoplasms
- Lung cancer
- Neoplasms
- Lung Neoplasms
Name | Location |
|---|
